UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002244 |
|---|---|
| Receipt number | R000002599 |
| Scientific Title | A phase 3 study of gemcitabine and S-1 compared with gemcitabine monotherapy in patients with unresectable advanced pancreatic cancer. |
| Date of disclosure of the study information | 2009/07/24 |
| Last modified on | 2016/04/12 19:52:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/07/23 22:21:20 | ||
| 2 | Update | 2010/07/19 11:18:47 | Primary outcomes Primary outcomes |
|
| 3 | Update | 2010/07/19 11:21:22 | Target sample size |
|
| 4 | Update | 2010/07/19 11:27:18 | Name of person sending information Organization Division name Address Organization Organization |
|
| 5 | Update | 2012/02/24 19:17:15 | Recruitment status |
|
| 6 | Update | 2016/04/12 19:52:28 | Recruitment status Publication of results |
